Intelligence for the journey from evidence to action
Medicines travel a long way before they reach a pharmacy. Evidence, regulation, economics, supply, and the practical work of implementation all influence what happens along that journey.
Medicines Intelligence is NEUVIOR’s technology centre, home to PHARMORIS and research into medicines implementation, economic value, regulatory intelligence, and pharmaceutical data.
We study how decisions are made, what it takes to put them into practice, and how their consequences can be understood afterwards. PHARMORIS brings these questions into the development of our medicines value operating system.
The questions behind better implementation
A promising opportunity needs a clear account of the evidence and the people who will act on it. It also needs an understanding of local capacity, expenditure, supply, and the work required to change an established process.
Our research examines these connections. How much expert review does an evidence tool require? Which costs appear during adoption? When does a recorded action become an observable outcome? How should a system help a professional recognise uncertainty or conflicting information?
Where the work lives
PHARMORIS brings source-linked evidence, human decisions, accountable implementation, and subsequent review into a connected workflow.
PHARMORIS-SCOT investigates AI-assisted prioritisation, regulatory dossier preparation, and deployment modelling for NHS generic-medicines adoption.
PHARMORIS-INDIA explores how the approach can respond to a defined local medicines problem, with local users and operating conditions shaping the development pathway.
Research that changes the product
We are developing work in implementation science, pharmaceutical economics, regulatory evidence, professional reliance on AI, and medicines access. The aim is to produce findings that help a team choose an approach, improve a workflow, or decide what a technology needs to do next.